Novel ZNFX1 Variants Associated With Refractory Anemia and Interstitial Lung Disease
Molecular Genetics & Genomic Medicine · 2026-11 · 14 (11)
DOI: 10.1002/mgg3.70329 ↗Abstract
ABSTRACT Background ZNFX1 deficiency is a rare inborn error of immunity characterized by recurrent infections, hyperinflammation, cytopenias, and multiorgan involvement. Owing to the limited number of reported cases, its clinical and molecular spectrum remains incompletely defined. Methods Clinical evaluation, whole‐exome sequencing (WES) of the proband, Sanger sequencing for variant validation and segregation analysis, RNA sequencing, AlphaFold‐based structural modeling, and interferon‐stimulated gene (ISG) expression analysis were performed. Variants were interpreted according to the American College of Medical Genetics and Genomics (ACMG) guidelines. Results A Chinese girl presented with refractory anemia, hyperinflammation, digital clubbing, developmental delay, and interstitial lung disease (ILD). WES of the proband identified three previously unreported ZNFX1 variants. Subsequent Sanger sequencing and segregation analysis confirmed that c.981dupA (p.Asp328Argfs*4) was paternally inherited, whereas c.1605_1630delinsGGGAATATCGTGGA (p.Asn535_Val543delinsLysGlyIleSerTrp) and c.2893G>A (p.Glu965Lys) were maternally inherited. According to ACMG criteria, one variant was classified as likely pathogenic and the other two as variants of uncertain significance. RNA sequencing demonstrated reduced ZNFX1 expression, while AlphaFold‐based modeling suggested local structural alterations. ISG expression analysis indicated activation of Type I interferon signaling. Conclusion We report a child with ZNFX1 deficiency carrying three previously unreported ZNFX1 variants associated with refractory anemia and ILD. These findings expand both the molecular and phenotypic spectrum of ZNFX1 deficiency and highlight the value of integrating genomic, transcriptomic, structural modeling, and ISG expression analyses for molecular diagnosis.
EUVIMED